RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
about
BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancerThe centrosome in human genetic disease.Myeloproliferative disorders: the centrosome connection.Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disordersMolecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.An image-based multi-label human protein subcellular localization predictor (iLocator) reveals protein mislocalizations in cancer tissuesComplex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse modelTyrosine kinase gene rearrangements in epithelial malignancies.Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.Mechanisms of receptor tyrosine kinase activation in cancer.The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
P2860
Q24685696-DFE29879-2E16-4CB5-8F11-3524F63CF5A8Q31106255-1D0A0BD0-6B05-4030-96FC-270FEEFD9D0EQ35079572-15683EB1-4314-4F96-A476-1937157F6363Q35549967-9ADE5E03-44A6-4426-A592-7AFF2BFDA22DQ36058438-41712277-E404-42FC-8713-EBCB62945337Q36233843-D410501D-5C6A-4480-8FF9-8BF107F4363CQ36374813-354512E3-55E8-4ED3-914E-7B3C3543A8BAQ37035285-399C63F9-3694-42DE-A529-4C457DC42824Q37043457-6346D633-0413-474B-850A-AB393920F453Q37205853-F122B6C2-FAB7-417E-BEFF-A5A602EE0415Q37515966-550F165E-136E-4C24-9055-B2AF5655767CQ38299702-AAAD1437-17E3-45FC-BA4D-19623630C0E4Q46319738-6662D0A5-370B-480B-82C4-58C7113EDB26Q47601932-9A73FA34-A377-449B-BD9C-0EFC91BC98BEQ49888000-85A7B7A7-C2DD-4051-9381-CB8DEEF3B542Q55314072-EFED5324-7AB3-430E-AF8E-81DB2688A42AQ58796314-1FA41135-E830-4D32-AF14-5E87C3518C32
P2860
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@ast
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@en
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@nl
type
label
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@ast
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@en
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@nl
prefLabel
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@ast
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@en
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@nl
P2093
P2860
P356
P1433
P1476
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203772
P407
P577
2000-08-31T00:00:00Z
P5875
P6179
1040855028